Neurology Devices Market
Neurology Devices Market Forecasts to 2030 - Global Analysis By Product (Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices and Other Products), End User (Hospitals, Ambulatory Surgery Centers, Specialty Center and Other End Users) and by Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $13.73 BN |
|
Projected Year Value (2030) |
US $21.85 BN |
|
CAGR (2023 - 2030) |
6.86% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Neurology Devices Market is accounted for $13.73 billion in 2023 and is expected to reach $21.85 billion by 2030 growing at a CAGR of 6.86% during the forecast period. Neurology is a branch of medicine that focuses on the examination, diagnosis, and treatment of disorders of the nervous system that impact the brain, spinal cord, and nerves. Moreover, the brain, spinal cord, and peripheral nerves are among the nervous systems affected by disorders that can be detected, monitored, and treated by medical devices referred to as neurology devices. On the other hand, neurosurgeons use neurosurgery devices as medical instruments to operate on patients' nervous systems, spines, and brains.
According to the World Population Ageing 2021 report, the Mexican population aged 65 years and older is projected to reach 9.31 million by 2030. Thus, the increasing aging population is more prone to develop neurological disorders which are expected to increase the demand for various neurology devices for diagnosing and treatment of the conditions, which is expected to fuel the market growth.
Market Dynamics:
Driver:
Increasing frequency of nervous diseases
Neurology device demand has surged due to rising rates of neurological disorders such as multiple sclerosis, epilepsy, Parkinson's disease, and Alzheimer's disease. Additionally, the need for sophisticated diagnostic tools, therapeutic devices, and monitoring systems has increased as the world's population ages and lifestyle factors increase the prevalence of these conditions. Due to their ability to enable accurate diagnosis, timely treatment, and early detection, neurology devices have become essential in the fight against these disorders.
Restraint:
Strict approval procedures for regulations
Clinical trials and safety evaluations are part of the stringent regulatory approval procedures that apply to neurology devices. Strict regulatory requirements may result in expensive development and protracted approval processes. Moreover, these difficulties frequently discourage new and smaller businesses from entering the market, which stifles competition and innovation.
Opportunity:
Quick advancements in technology
The market for neurology devices is ripe with opportunity thanks to continuous technological advancements. Advanced neuroimaging, telemedicine, and brain-computer interfaces (BCIs) are examples of emerging technologies that are transforming patient care, treatment, and diagnosis. Furthermore, these advancements make it possible to create neurology devices that are more accurate and efficient, which will improve neurological condition diagnosis and treatment while also potentially improving patient outcomes.
Threat:
Policies with restricted reimbursement
The adoption of neurology devices may be impacted by inadequate or limited reimbursement policies in some areas. Moreover, insufficient compensation may result in higher out-of-pocket costs for patients and medical professionals, which may restrict access to these devices and impede market expansion.
Covid-19 Impact:
The market for neurology devices has been affected by the COVID-19 pandemic in numerous ways. Although the pandemic caused delays in clinical trials and research projects and disruptions in the supply chain, it also highlighted the significance of advanced telemedicine and remote monitoring solutions for patients with neurology. Additionally, the demand for remote patient monitoring, diagnosis, and consultations sparked a surge in interest in digital health technologies that are predicted to have a long-lasting effect on the industry.
The Neurostimulation Devices segment is expected to be the largest during the forecast period
The neurostimulation devices segment holds the largest share in the neurology devices market. Electrical impulses are used by neurostimulation devices to alter the nervous system's activity. They are used to treat a range of neurological disorders, including depression, epilepsy, Parkinson's disease, and chronic pain. These gadgets consist of transcranial magnetic stimulators, deep brain stimulators, and spinal cord stimulators. This market is becoming more and more well-known due to the rising incidence of neurological conditions and the growing use of neurostimulation treatments. Furthermore, the continuous progress in technology and the growing range of uses for neurostimulation devices bolster their market share.
The Ambulatory Surgery Centers segment is expected to have the highest CAGR during the forecast period
The market for neurology devices is growing at the highest CAGR in the Ambulatory Surgery Centers (ASCs) segment. These specialized centers perform medical and surgical procedures without the need for an overnight stay in a hospital. The development of ASCs has been spurred by the growing demand for convenient, affordable outpatient care as well as advances in minimally invasive procedures. Moreover, patients gain from faster healing and lower expenses, and healthcare providers can work more productively. To increase their appeal, ASCs frequently provide a broad range of specialized services.
Region with largest share:
With the largest market share, North America is the market leader for neurology devices. The reason for this region's leadership is its extensive patient base of neurological disorders, high healthcare spending, considerable R&D, and well-established healthcare infrastructure. Due to its sophisticated medical technologies, strong research institutions, and emphasis on neurological care innovation, the United States is a major player in the global market for neurology devices. Moreover, North America's leadership in the global neurology device market is further cemented by its proactive response to new healthcare challenges.
Region with highest CAGR:
In terms of the market for neurology devices, the Asia-Pacific region has the highest CAGR. A number of factors, including growing economic development, increased healthcare awareness, and increased access to healthcare services, are driving this incredible growth. With large investments from healthcare companies, the Asia-Pacific area has emerged as a key hub for clinical trials, medical research, and development. However, due to this, the region is seeing quick improvements in digital health solutions, novel neurological devices, and healthcare infrastructure, which positions it as a key driver of growth and innovation in the global market for neurology devices.
Key players in the market
Some of the key players in Neurology Devices market include Hitachi, Ltd, LivaNova PLC, Abbott Laboratories, Natus Medical Incorporated, MicroPort Scientific Corporation, B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation , Nihon Kohden Corporation, Johnson and Johnson, Medtronic PLC, Penumbra, Inc, Avanos Medical, Inc, GE Healthcare, Boston Scientific Corporation, Stryker Corporation , Zimmer Biomet Holdings, Inc, Neuropace, Inc, Helius Medical Technologies, Inc, W.L. Gore & Associates, Inc and HeadsafeIP Pty Ltd.
Key Developments:
In September 2023, Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. Together, the companies have worked on connected diabetes solutions since 2017. Developed by Bigfoot Biomedical, Bigfoot Unity is a smart insulin management system. It features connected insulin pen caps that use integrated continuous glucose monitoring (iCGM) data and healthcare provider instructions.
In May 2023, Medtronic plc, Ireland-headquartered healthcare technology firm, has entered into a set of definitive agreements to acquire South Korea-based EOFlow Co., manufacturer of the EOPatch device — a tubeless, wearable and fully disposable insulin delivery device. To the extent that all the public shares participate in the tender offer, the total consideration for the acquisition of the shares in EOFlow would be KRW 971 billion, or $738 million, at current exchange rates. The acquisition is expected to close in the second half of calendar year 2023.
In December 2022, Integra LifeSciences Holding Corporation, a leading global medical technology company, today announced that it entered into a definitive agreement to acquire Surgical Innovation Associates (SIA), which develops, markets and sells DuraSorb®, a resorbable synthetic matrix for plastic and reconstructive surgery. This acquisition will advance Integra’s global strategy in breast reconstruction, expanding plans to access the U.S. market with devices specifically approved by the FDA for use in implant-based breast reconstruction (IBBR) procedures.
Products Covered:
• Neurostimulation Devices
• Neurosurgery Devices
• Interventional Neurology Devices
• Cerebrospinal Fluid Management Devices
• Other Products
End Users Covered:
• Hospitals
• Ambulatory Surgery Centers
• Specialty Center
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Neurology Devices Market, By Product
5.1 Introduction
5.2 Neurostimulation Devices
5.2.1 Spinal Cord Stimulators
5.2.2 Deep Brain Stimulators
5.2.3 Sacral Nerve Stimulators
5.2.4 Vagus Nerve Stimulators
5.3 Neurosurgery Devices
5.3.1 Neuroendoscopy
5.3.2 Neurosurgery Navigations
5.4 Interventional Neurology Devices
5.4.1 Embolization Devices
5.4.2 Revascularization Devices
5.4.3 Thrombectomy Devices
5.4.4 Embolic Protection Devices
5.4.5 Accessory Devices
5.5 Cerebrospinal Fluid Management Devices
5.5.1 CSF Shunts
5.5.2 External Drainage System
5.6 Other Products
6 Global Neurology Devices Market, By End User
6.1 Introduction
6.2 Hospitals
6.3 Ambulatory Surgery Centers
6.4 Specialty Center
6.5 Other End Users
7 Global Neurology Devices Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Hitachi, Ltd
9.2 LivaNova PLC
9.3 Abbott Laboratories
9.4 Natus Medical Incorporated
9.5 MicroPort Scientific Corporation
9.6 B. Braun Melsungen AG
9.7 Integra LifeSciences Holdings Corporation
9.8 Nihon Kohden Corporation
9.9 Johnson and Johnson
9.10 Medtronic PLC
9.11 Penumbra, Inc
9.12 Avanos Medical, Inc
9.13 GE Healthcare
9.14 Boston Scientific Corporation
9.15 Stryker Corporation
9.16 Zimmer Biomet Holdings, Inc
9.17 Neuropace, Inc
9.18 Helius Medical Technologies, Inc
9.19 W.L. Gore & Associates, Inc
9.20 HeadsafeIP Pty Ltd.
List of Tables
1 Global Neurology Devices Market Outlook, By Region (2021-2030) ($MN)
2 Global Neurology Devices Market Outlook, By Product (2021-2030) ($MN)
3 Global Neurology Devices Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
4 Global Neurology Devices Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
5 Global Neurology Devices Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
6 Global Neurology Devices Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
7 Global Neurology Devices Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
8 Global Neurology Devices Market Outlook, By Neurosurgery Devices (2021-2030) ($MN)
9 Global Neurology Devices Market Outlook, By Neuroendoscopy (2021-2030) ($MN)
10 Global Neurology Devices Market Outlook, By Neurosurgery Navigations (2021-2030) ($MN)
11 Global Neurology Devices Market Outlook, By Interventional Neurology Devices (2021-2030) ($MN)
12 Global Neurology Devices Market Outlook, By Embolization Devices (2021-2030) ($MN)
13 Global Neurology Devices Market Outlook, By Revascularization Devices (2021-2030) ($MN)
14 Global Neurology Devices Market Outlook, By Thrombectomy Devices (2021-2030) ($MN)
15 Global Neurology Devices Market Outlook, By Embolic Protection Devices (2021-2030) ($MN)
16 Global Neurology Devices Market Outlook, By Accessory Devices (2021-2030) ($MN)
17 Global Neurology Devices Market Outlook, By Cerebrospinal Fluid Management Devices (2021-2030) ($MN)
18 Global Neurology Devices Market Outlook, By CSF Shunts (2021-2030) ($MN)
19 Global Neurology Devices Market Outlook, By External Drainage System (2021-2030) ($MN)
20 Global Neurology Devices Market Outlook, By Other Products (2021-2030) ($MN)
21 Global Neurology Devices Market Outlook, By End User (2021-2030) ($MN)
22 Global Neurology Devices Market Outlook, By Hospitals (2021-2030) ($MN)
23 Global Neurology Devices Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
24 Global Neurology Devices Market Outlook, By Specialty Center (2021-2030) ($MN)
25 Global Neurology Devices Market Outlook, By Other End Users (2021-2030) ($MN)
26 North America Neurology Devices Market Outlook, By Country (2021-2030) ($MN)
27 North America Neurology Devices Market Outlook, By Product (2021-2030) ($MN)
28 North America Neurology Devices Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
29 North America Neurology Devices Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
30 North America Neurology Devices Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
31 North America Neurology Devices Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
32 North America Neurology Devices Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
33 North America Neurology Devices Market Outlook, By Neurosurgery Devices (2021-2030) ($MN)
34 North America Neurology Devices Market Outlook, By Neuroendoscopy (2021-2030) ($MN)
35 North America Neurology Devices Market Outlook, By Neurosurgery Navigations (2021-2030) ($MN)
36 North America Neurology Devices Market Outlook, By Interventional Neurology Devices (2021-2030) ($MN)
37 North America Neurology Devices Market Outlook, By Embolization Devices (2021-2030) ($MN)
38 North America Neurology Devices Market Outlook, By Revascularization Devices (2021-2030) ($MN)
39 North America Neurology Devices Market Outlook, By Thrombectomy Devices (2021-2030) ($MN)
40 North America Neurology Devices Market Outlook, By Embolic Protection Devices (2021-2030) ($MN)
41 North America Neurology Devices Market Outlook, By Accessory Devices (2021-2030) ($MN)
42 North America Neurology Devices Market Outlook, By Cerebrospinal Fluid Management Devices (2021-2030) ($MN)
43 North America Neurology Devices Market Outlook, By CSF Shunts (2021-2030) ($MN)
44 North America Neurology Devices Market Outlook, By External Drainage System (2021-2030) ($MN)
45 North America Neurology Devices Market Outlook, By Other Products (2021-2030) ($MN)
46 North America Neurology Devices Market Outlook, By End User (2021-2030) ($MN)
47 North America Neurology Devices Market Outlook, By Hospitals (2021-2030) ($MN)
48 North America Neurology Devices Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
49 North America Neurology Devices Market Outlook, By Specialty Center (2021-2030) ($MN)
50 North America Neurology Devices Market Outlook, By Other End Users (2021-2030) ($MN)
51 Europe Neurology Devices Market Outlook, By Country (2021-2030) ($MN)
52 Europe Neurology Devices Market Outlook, By Product (2021-2030) ($MN)
53 Europe Neurology Devices Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
54 Europe Neurology Devices Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
55 Europe Neurology Devices Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
56 Europe Neurology Devices Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
57 Europe Neurology Devices Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
58 Europe Neurology Devices Market Outlook, By Neurosurgery Devices (2021-2030) ($MN)
59 Europe Neurology Devices Market Outlook, By Neuroendoscopy (2021-2030) ($MN)
60 Europe Neurology Devices Market Outlook, By Neurosurgery Navigations (2021-2030) ($MN)
61 Europe Neurology Devices Market Outlook, By Interventional Neurology Devices (2021-2030) ($MN)
62 Europe Neurology Devices Market Outlook, By Embolization Devices (2021-2030) ($MN)
63 Europe Neurology Devices Market Outlook, By Revascularization Devices (2021-2030) ($MN)
64 Europe Neurology Devices Market Outlook, By Thrombectomy Devices (2021-2030) ($MN)
65 Europe Neurology Devices Market Outlook, By Embolic Protection Devices (2021-2030) ($MN)
66 Europe Neurology Devices Market Outlook, By Accessory Devices (2021-2030) ($MN)
67 Europe Neurology Devices Market Outlook, By Cerebrospinal Fluid Management Devices (2021-2030) ($MN)
68 Europe Neurology Devices Market Outlook, By CSF Shunts (2021-2030) ($MN)
69 Europe Neurology Devices Market Outlook, By External Drainage System (2021-2030) ($MN)
70 Europe Neurology Devices Market Outlook, By Other Products (2021-2030) ($MN)
71 Europe Neurology Devices Market Outlook, By End User (2021-2030) ($MN)
72 Europe Neurology Devices Market Outlook, By Hospitals (2021-2030) ($MN)
73 Europe Neurology Devices Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
74 Europe Neurology Devices Market Outlook, By Specialty Center (2021-2030) ($MN)
75 Europe Neurology Devices Market Outlook, By Other End Users (2021-2030) ($MN)
76 Asia Pacific Neurology Devices Market Outlook, By Country (2021-2030) ($MN)
77 Asia Pacific Neurology Devices Market Outlook, By Product (2021-2030) ($MN)
78 Asia Pacific Neurology Devices Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
79 Asia Pacific Neurology Devices Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
80 Asia Pacific Neurology Devices Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
81 Asia Pacific Neurology Devices Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
82 Asia Pacific Neurology Devices Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
83 Asia Pacific Neurology Devices Market Outlook, By Neurosurgery Devices (2021-2030) ($MN)
84 Asia Pacific Neurology Devices Market Outlook, By Neuroendoscopy (2021-2030) ($MN)
85 Asia Pacific Neurology Devices Market Outlook, By Neurosurgery Navigations (2021-2030) ($MN)
86 Asia Pacific Neurology Devices Market Outlook, By Interventional Neurology Devices (2021-2030) ($MN)
87 Asia Pacific Neurology Devices Market Outlook, By Embolization Devices (2021-2030) ($MN)
88 Asia Pacific Neurology Devices Market Outlook, By Revascularization Devices (2021-2030) ($MN)
89 Asia Pacific Neurology Devices Market Outlook, By Thrombectomy Devices (2021-2030) ($MN)
90 Asia Pacific Neurology Devices Market Outlook, By Embolic Protection Devices (2021-2030) ($MN)
91 Asia Pacific Neurology Devices Market Outlook, By Accessory Devices (2021-2030) ($MN)
92 Asia Pacific Neurology Devices Market Outlook, By Cerebrospinal Fluid Management Devices (2021-2030) ($MN)
93 Asia Pacific Neurology Devices Market Outlook, By CSF Shunts (2021-2030) ($MN)
94 Asia Pacific Neurology Devices Market Outlook, By External Drainage System (2021-2030) ($MN)
95 Asia Pacific Neurology Devices Market Outlook, By Other Products (2021-2030) ($MN)
96 Asia Pacific Neurology Devices Market Outlook, By End User (2021-2030) ($MN)
97 Asia Pacific Neurology Devices Market Outlook, By Hospitals (2021-2030) ($MN)
98 Asia Pacific Neurology Devices Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
99 Asia Pacific Neurology Devices Market Outlook, By Specialty Center (2021-2030) ($MN)
100 Asia Pacific Neurology Devices Market Outlook, By Other End Users (2021-2030) ($MN)
101 South America Neurology Devices Market Outlook, By Country (2021-2030) ($MN)
102 South America Neurology Devices Market Outlook, By Product (2021-2030) ($MN)
103 South America Neurology Devices Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
104 South America Neurology Devices Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
105 South America Neurology Devices Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
106 South America Neurology Devices Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
107 South America Neurology Devices Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
108 South America Neurology Devices Market Outlook, By Neurosurgery Devices (2021-2030) ($MN)
109 South America Neurology Devices Market Outlook, By Neuroendoscopy (2021-2030) ($MN)
110 South America Neurology Devices Market Outlook, By Neurosurgery Navigations (2021-2030) ($MN)
111 South America Neurology Devices Market Outlook, By Interventional Neurology Devices (2021-2030) ($MN)
112 South America Neurology Devices Market Outlook, By Embolization Devices (2021-2030) ($MN)
113 South America Neurology Devices Market Outlook, By Revascularization Devices (2021-2030) ($MN)
114 South America Neurology Devices Market Outlook, By Thrombectomy Devices (2021-2030) ($MN)
115 South America Neurology Devices Market Outlook, By Embolic Protection Devices (2021-2030) ($MN)
116 South America Neurology Devices Market Outlook, By Accessory Devices (2021-2030) ($MN)
117 South America Neurology Devices Market Outlook, By Cerebrospinal Fluid Management Devices (2021-2030) ($MN)
118 South America Neurology Devices Market Outlook, By CSF Shunts (2021-2030) ($MN)
119 South America Neurology Devices Market Outlook, By External Drainage System (2021-2030) ($MN)
120 South America Neurology Devices Market Outlook, By Other Products (2021-2030) ($MN)
121 South America Neurology Devices Market Outlook, By End User (2021-2030) ($MN)
122 South America Neurology Devices Market Outlook, By Hospitals (2021-2030) ($MN)
123 South America Neurology Devices Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
124 South America Neurology Devices Market Outlook, By Specialty Center (2021-2030) ($MN)
125 South America Neurology Devices Market Outlook, By Other End Users (2021-2030) ($MN)
126 Middle East & Africa Neurology Devices Market Outlook, By Country (2021-2030) ($MN)
127 Middle East & Africa Neurology Devices Market Outlook, By Product (2021-2030) ($MN)
128 Middle East & Africa Neurology Devices Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
129 Middle East & Africa Neurology Devices Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
130 Middle East & Africa Neurology Devices Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
131 Middle East & Africa Neurology Devices Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
132 Middle East & Africa Neurology Devices Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
133 Middle East & Africa Neurology Devices Market Outlook, By Neurosurgery Devices (2021-2030) ($MN)
134 Middle East & Africa Neurology Devices Market Outlook, By Neuroendoscopy (2021-2030) ($MN)
135 Middle East & Africa Neurology Devices Market Outlook, By Neurosurgery Navigations (2021-2030) ($MN)
136 Middle East & Africa Neurology Devices Market Outlook, By Interventional Neurology Devices (2021-2030) ($MN)
137 Middle East & Africa Neurology Devices Market Outlook, By Embolization Devices (2021-2030) ($MN)
138 Middle East & Africa Neurology Devices Market Outlook, By Revascularization Devices (2021-2030) ($MN)
139 Middle East & Africa Neurology Devices Market Outlook, By Thrombectomy Devices (2021-2030) ($MN)
140 Middle East & Africa Neurology Devices Market Outlook, By Embolic Protection Devices (2021-2030) ($MN)
141 Middle East & Africa Neurology Devices Market Outlook, By Accessory Devices (2021-2030) ($MN)
142 Middle East & Africa Neurology Devices Market Outlook, By Cerebrospinal Fluid Management Devices (2021-2030) ($MN)
143 Middle East & Africa Neurology Devices Market Outlook, By CSF Shunts (2021-2030) ($MN)
144 Middle East & Africa Neurology Devices Market Outlook, By External Drainage System (2021-2030) ($MN)
145 Middle East & Africa Neurology Devices Market Outlook, By Other Products (2021-2030) ($MN)
146 Middle East & Africa Neurology Devices Market Outlook, By End User (2021-2030) ($MN)
147 Middle East & Africa Neurology Devices Market Outlook, By Hospitals (2021-2030) ($MN)
148 Middle East & Africa Neurology Devices Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
149 Middle East & Africa Neurology Devices Market Outlook, By Specialty Center (2021-2030) ($MN)
150 Middle East & Africa Neurology Devices Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
